Demographic and clinical data of patients included in this study
| ID | Age/sex | History/reason for CHCT | CHCT Caff (g) | CHCT Halo (g) | MH status | Clinical signs/symptoms | Histopathology | Clinical index | Fasting glucose (mmol/liter) | Calcium index | RYR1/CACNA1S genetics |
| 139 | 43/F | FH | 0 | 0 | MHN | No symptoms | Scattered atrophic polygonal fibers | 1.67 | 4.0 | Not done | Not done |
| 143 | 38/F | Family w’ myopathy | 0 | 0.8 | MHS | Heat stroke and cramps | Negative | 6.67 | 5.7 | 7.5 | RYR1 p.R682Q |
| 144 | 48/M | FH | 0 | 0.5 | MHN | No symptoms | Negative | 0 | 6.1 | Not done | CACNA1S p.G1210R |
| 145 | 24/M | Self | 0 | 1.2 | MHS | Cramps and rhabdomyo | Negative | 6.67 | 6.9 | 7.5 | CACNA1S p.R1229H |
| 146 | 26/F | FH | 0.5 | 1.8 | MHS | Cramps | Negative | 1.67 | 5.5 | Not done | RYR1 p.R3502W |
| 173 | 38/M | FH | 0.1 | 3.4 | MHS | No symptoms | Negative | 1.67 | 4.6 | 3.33 | RYR1 p.Y3540F CACNA1S p.T1354S |
| 277 | 51/M | FH | 0 | 0.2 | MHN | No symptoms | Negative | 0 | 5.4 | 6.67 | Negative |
| ID | Age/sex | History/reason for CHCT | CHCT Caff (g) | CHCT Halo (g) | MH status | Clinical signs/symptoms | Histopathology | Clinical index | Fasting glucose (mmol/liter) | Calcium index | RYR1/CACNA1S genetics |
| 139 | 43/F | FH | 0 | 0 | MHN | No symptoms | Scattered atrophic polygonal fibers | 1.67 | 4.0 | Not done | Not done |
| 143 | 38/F | Family w’ myopathy | 0 | 0.8 | MHS | Heat stroke and cramps | Negative | 6.67 | 5.7 | 7.5 | RYR1 p.R682Q |
| 144 | 48/M | FH | 0 | 0.5 | MHN | No symptoms | Negative | 0 | 6.1 | Not done | CACNA1S p.G1210R |
| 145 | 24/M | Self | 0 | 1.2 | MHS | Cramps and rhabdomyo | Negative | 6.67 | 6.9 | 7.5 | CACNA1S p.R1229H |
| 146 | 26/F | FH | 0.5 | 1.8 | MHS | Cramps | Negative | 1.67 | 5.5 | Not done | RYR1 p.R3502W |
| 173 | 38/M | FH | 0.1 | 3.4 | MHS | No symptoms | Negative | 1.67 | 4.6 | 3.33 | RYR1 p.Y3540F CACNA1S p.T1354S |
| 277 | 51/M | FH | 0 | 0.2 | MHN | No symptoms | Negative | 0 | 5.4 | 6.67 | Negative |